| Literature DB >> 35821236 |
Ashish Sarraju1, Summer Ngo1, Melanie Ashland2, David Scheinker3, Fatima Rodriguez4,5.
Abstract
Hispanic populations generally experience more adverse socioeconomic conditions yet demonstrate lower mortality compared with Non-Hispanic White (NHW) populations in the US. This finding of a mortality advantage is well-described as the "Hispanic paradox." The Coronavirus Disease 2019 (COVID-19) pandemic has disproportionately affected Hispanic populations. To quantify these effects, we evaluated US national and county-level trends in Hispanic versus NHW mortality from 2011 through 2020. We found that a previously steady Hispanic mortality advantage significantly decreased in 2020, potentially driven by COVID-19-attributable Hispanic mortality. Nearly 16% of US counties experienced a reversal of their pre-pandemic Hispanic mortality advantage such that their Hispanic mortality exceeded NHW mortality in 2020. An additional 50% experienced a decrease in a pre-pandemic Hispanic mortality advantage. Our work provides a quantitative understanding of the disproportionate burden of the pandemic on Hispanic health and the Hispanic paradox and provides a renewed impetus to tackle the factors driving these concerning disparities.Entities:
Mesh:
Year: 2022 PMID: 35821236 PMCID: PMC9276777 DOI: 10.1038/s41598-022-15916-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1(A) National trends in Hispanic and NHW AAMRs in the US, 2011–2020. The first graph shows the individual Hispanic and NHW AAMRs (deaths per 100,000 individuals) and 95% confidence intervals by year. The second graph shows trends in the absolute national Hispanic mortality advantage (deaths per 100,000 individuals) by year when defined as the average NHW AAMR minus the average Hispanic AAMR. The previously steady national Hispanic mortality advantage, defined by the difference in the national NHW AAMR and Hispanic AAMR point estimates, decreased by approximately 50% from 2019 (214 fewer Hispanic vs NHW deaths per 100,000) to 2020 (109 fewer Hispanic vs NHW deaths per 100,000). (B) County-level trends in Hispanic vs NHW mortality in the US, 2019–2020. Of 618 counties, 99 (16%) experienced a reversal of a 2019 Hispanic mortality advantage in 2020 such that Hispanic mortality newly exceeded NHW mortality (average 2019 to 2020 change of 312 excess Hispanic vs NHW deaths per 100,000, 95% CI 274–348); 306 counties (50%) experienced a significant decrease in the magnitude of their 2019 Hispanic mortality advantage (average 2019 to 2020 change of 111 excess Hispanic vs NHW deaths per 100,000, 95% CI 99–124); and only 21 counties (3%) experienced a new Hispanic mortality advantage in 2020 such that NHW mortality was newly higher than Hispanic mortality (average 2019 to 2020 change of 290 fewer Hispanic vs NHW deaths per 100,000, 95% CI 235–345). The “other” counties group includes those with a 2019 Hispanic mortality advantage which further increased in 2020 and those with no Hispanic mortality advantage in both 2019 and 2020 (average 2019–2020 change of 67 fewer Hispanic vs NHW deaths per 100,000, 95% CI 48–87). Gray areas indicate lack of county-level data. This map was generated using RStudio, 1.4.1106 (http://www.rstudio.com/). Abbreviations: AAMR age-adjusted mortality rate, NHW Non-Hispanic White, HL Hispanic or Latino, US United States.
Cause-specific Hispanic and Non-Hispanic White age-adjusted mortality in the US, 2019–2020.
| 2020 Leading Causes of Death | Hispanic | Non-hispanic white | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 2020 | 2020–2019 AAMR ratio (95% CI) | 2019 | 2020 | 2020–2019 AAMR ratio (95% CI) | |||||
| Deaths | AAMR (95% CI) | Deaths | AAMR (95% CI) | Deaths | AAMR (95% CI) | Deaths | AAMR (95% CI) | |||
| COVID-19 | 0 | 65,237 | 155.5 (154.3, 156.7) | 0 | 209,606 | 66.3 (66.0, 66.6) | ||||
| Heart disease | 41,794 | 111.3 (110.2, 112.4) | 48,323 | 122.7 (121.6, 123.9) | 1.10 (0.34, 3.56) | 513,673 | 165.8 (165.3, 166.2) | 530,355 | 170.1 (169.6, 170.6) | 1.03 (0.70, 1.52) |
| Malignant neoplasms | 43,079 | 105.6 (104.6, 106.6) | 43,942 | 103.6 (102.5, 104.6) | 0.98 (0.37, 2.61) | 462,064 | 151.4 (150.9, 151.8) | 463,160 | 149.9 (149.4, 150.3) | 0.99 (0.67, 1.47) |
| Unintentional injuries | 18,874 | 35.1 (34.6, 35.6) | 23,152 | 41.2 (40.7, 41.8) | 1.17 (0.65, 2.11) | 125,755 | 54.6 (54.3, 55.0) | 141,335 | 62.8 (62.4, 63.1) | 1.15 (0.78, 1.70) |
| Diabetes mellitus | 10,166 | 25.6 (25.1, 26.1) | 13,370 | 34.9 (34.3, 35.5) | 1.21 (0.67, 2.18) | 57,325 | 19 (18.9, 19.2) | 64,098 | 21.1 (20.9, 21.3) | 1.11 (0.91, 1.35) |
| Cerebrovascular diseases | 11,959 | 32.8 (32.2, 33.4) | 12,832 | 30.9 (30.4, 31.5) | 1.06 (0.59, 1.91) | 111,060 | 35.6 (35.4, 35.8) | 116,752 | 37.1 (36.9, 37.3) | 1.04 (0.86, 1.27) |
Abbreviations: AAMR age-adjusted mortality rate, deaths per 100,000 individuals, CI confidence interval, COVID-19 Coronavirus Disease 2019.
US county-level changes in Hispanic versus Non-Hispanic White age-adjusted mortality categorized according to effect on the Hispanic mortality advantage, 2019–2020.
| Category | N (%) counties (total = 618) | Average county-level 2019–2020 change (95% CI) |
|---|---|---|
| 2020 reversal of prior 2019 Hispanic mortality advantage | 99 (16) | 312 excess Hispanic vs. NHW deaths per 100,000 (274–348) |
| 2020 narrowing of prior 2019 Hispanic mortality advantage | 306 (50) | 111 excess Hispanic vs. NHW deaths per 100,000 (99–124) |
| 2020 gain of new Hispanic mortality advantage | 21 (3) | 290 fewer Hispanic vs. NHW deaths per 100,000 (235–345) |
| Other* | 192 (31) | 67 fewer Hispanic vs NHW deaths per 100,000 (48–87) |
Abbreviations: NHW Non-Hispanic White.
*Other—includes those with a 2019 Hispanic mortality advantage which further increased in 2020 and those with no Hispanic mortality advantage in both 2019 and 2020.